National Marrow Donor Program Executive and Leadership Team

Amy Ronneberg, the Chief Executive Officer at National Marrow Donor Program, directs the organization's strategic vision and overall operational framework. Overseeing all major initiatives, Ronneberg ensures alignment with the core mission of advancing cures and saving lives through cellular therapy. This leadership position involves guiding the organization through evolving healthcare landscapes and technological advancements, maintaining a focus on patient access and donor engagement. Amy Ronneberg drives the expansion of services and partnerships, solidifying the organization's position as a leader in hematopoietic stem cell transplantation and cellular therapies. The Chief Executive Officer's responsibilities extend to fostering a culture of innovation and excellence across all departments, ensuring the organization effectively meets the needs of patients and the medical community worldwide.

Katherine Heyerdahl, the Chief Financial Officer at National Marrow Donor Program, manages the organization's financial health and strategic fiscal planning. Overseeing all financial operations, Heyerdahl ensures robust resource allocation to support critical research, patient services, and technological development. This role involves rigorous budget management, financial forecasting, and the implementation of sound financial controls to maintain organizational sustainability and growth. Katherine Heyerdahl drives initiatives to optimize financial performance and secure funding necessary for expanding the organization's life-saving capabilities. The Chief Financial Officer's oversight extends to compliance, risk management, and reporting, providing essential financial insights to the executive team and board to inform strategic decision-making and ensure long-term operational viability.

Komal Khoja, the President at National Marrow Donor Program, leads key organizational initiatives and drives strategic partnerships to advance the mission of saving lives. Overseeing critical operational functions, Khoja ensures seamless execution of programs that connect donors with patients needing transplants. This leadership position involves fostering collaboration across departments and with external stakeholders to enhance patient access to life-saving treatments. Komal Khoja champions initiatives aimed at expanding the donor registry and improving the efficiency of transplant processes. The President's focus includes driving growth, optimizing service delivery, and ensuring the organization effectively addresses the evolving needs of the patient and medical communities.

Robert Hanson, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer at National Marrow Donor Program, architects and executes the organization's comprehensive technology strategy. Overseeing all aspects of information technology, cybersecurity, and data privacy, Hanson ensures the secure and efficient operation of critical systems supporting donor registries and patient treatments. This multifaceted role involves driving innovation in digital infrastructure, safeguarding sensitive data, and ensuring compliance with evolving data protection regulations. Robert Hanson leads the development and implementation of advanced technological solutions that enhance operational efficiency and expand the organization's reach. The Chief Technology Officer & Chief Information Security Officer's mandate includes fortifying the organization's digital defenses against emerging threats and leveraging technology to accelerate the discovery and delivery of cellular therapies.

Steven Devine, the Chief Medical Officer at National Marrow Donor Program, provides critical medical leadership and strategic direction for all clinical operations and research initiatives. Overseeing the medical aspects of donor selection, patient treatment protocols, and the advancement of cellular therapies, Devine ensures the highest standards of patient care and safety. This role involves guiding the organization's medical research agenda, fostering collaborations with healthcare institutions, and translating scientific discoveries into tangible patient benefits. Steven Devine drives the continuous improvement of medical practices and the expansion of treatment options for patients with life-threatening diseases. The Chief Medical Officer's expertise is essential in navigating complex medical challenges and ensuring the organization remains at the forefront of hematology and oncology advancements.